Hospital
Dardanelle Regional, LLC
Dardanelle Regional, LLC was paid $1.05M by Medicaid between Jun 2019 and Dec 2024, across 77 billing codes. Its largest line is 90853, Group psychotherapy (other than of a multiple-family group) — 21% of everything it billed.
33Billing provider infoDARDANELLE REGIONAL, LLC
DARDANELLE, AR 72834
DARDANELLE, AR 72834
33aNPI1184629594assigned 06/14/2005
33bProvider typeCritical Access Hospital
28Total paid$1.05M
24GClaims57,319
24DCodes billed77
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#14 of 34
Median peer was paid$773K
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 4,350 | $28K | |
| 2020 | 9,128 | $192K | |
| 2021 | 11,451 | $251K | |
| 2022 | 10,976 | $265K | |
| 2023 | 11,020 | $187K | |
| 2024incomplete | 10,394 | $128K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90853 | Group psychotherapy (other than of a multiple-family group) | 21% | 3,010 | 423 | $222K |
| 80053 | Comprehensive metabolic panel | 15% | 7,938 | 5,641 | $158K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.3% | 1,351 | 787 | $77K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.5% | 7,007 | 4,785 | $69K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.5% | 1,341 | 962 | $68K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.9% | 705 | 148 | $41K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 1,937 | 1,499 | $33K |
| 80061 | Lipid panel | 3.1% | 3,897 | 2,912 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 175 | 139 | $27K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 2.5% | 996 | 858 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 2,869 | 2,072 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 1,136 | 746 | $22K |
65 more codes
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 1,139 | $21K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.8% | 907 | $19K |
| 99283 | Emergency room visit (moderate) | 1.7% | 506 | $18K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.4% | 329 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.4% | 2,084 | $15K |
| 85027 | 1.3% | 2,154 | $14K | |
| 99213 | Doctor's office visit, returning patient (routine) | 1.2% | 825 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 1,866 | $12K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 304 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 522 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 874 | $8K |
| 80050 | General health panel | <1% | 155 | $7K |
| 81001 | <1% | 2,219 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,416 | $7K |
| 99285 | Emergency room visit (most serious) | <1% | 336 | $6K |
| 83880 | <1% | 470 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 698 | $5K |
| 87070 | <1% | 528 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 74 | $5K |
| 94760 | <1% | 590 | $5K | |
| 84484 | <1% | 792 | $4K | |
| 82570 | <1% | 628 | $4K | |
| 82043 | <1% | 820 | $4K | |
| 83690 | <1% | 506 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 213 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 212 | $2K |
| 80051 | <1% | 95 | $2K | |
| 86710 | <1% | 151 | $2K | |
| 82728 | <1% | 226 | $2K | |
| 82607 | <1% | 178 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $2K |
| 73562 | <1% | 55 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 314 | $1K |
| 87186 | <1% | 224 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 70 | $1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 82 | $960.42 |
| 83540 | <1% | 182 | $747.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 527 | $707.88 |
| 72100 | <1% | 17 | $687.97 | |
| 82553 | <1% | 70 | $647.25 | |
| 81025 | <1% | 79 | $613.98 | |
| 99284 | Emergency room visit (serious) | <1% | 67 | $562.94 |
| 87077 | <1% | 15 | $526.35 | |
| 84520 | <1% | 135 | $511.46 | |
| 84439 | <1% | 42 | $365.29 | |
| 82550 | <1% | 87 | $310.77 | |
| 84450 | <1% | 101 | $292.54 | |
| 81003 | <1% | 108 | $280.17 | |
| 82310 | <1% | 98 | $269.44 | |
| 82947 | <1% | 94 | $218.40 | |
| 84155 | <1% | 75 | $214.26 | |
| 82247 | <1% | 75 | $198.23 | |
| 84075 | <1% | 75 | $196.41 | |
| 99497 | <1% | 79 | $182.64 | |
| 84460 | <1% | 75 | $162.24 | |
| 82040 | <1% | 75 | $134.52 | |
| 83735 | <1% | 52 | $95.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 55 | $66.65 |
| 90686 | <1% | 40 | $55.12 | |
| 0001A | <1% | 13 | $16.94 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 35 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 40 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 39 | $0.00 |
| 0002A | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLEY, BRANDY (CONTROLLER)
| Provider | Location | Paid |
|---|---|---|
| Dardanelle Regional, LLC | Dardanelle, AR | $247K |
| Dardanelle Regional, LLC | Dardanelle, AR | $140.10 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.